Skip to content

ADTRAN Holdings, Inc. ADTN Reduction Of Research And Development Expense Recognized

Reduction Of Research And Development Expense Recognized at other companies

IBT
IbottaIBTA
$22.65M-42.0%
Replimune Group logo
Replimune GroupREPL
$341K-9.3%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$6.06M-47.2%
Adient logo
AdientADNT
$72M+2.9%
Falcon's Beyond Global logo
Falcon's Beyond GlobalFBYD
$49.75K+11.2%
Parker-Hannifin logo
Parker-HannifinPH
$172M+17.8%

Other financials

Income statement

See full
Revenue$286.1M+15.5%
Gross profit$113.0M+18.7%
Operating income$6.4M+261%
Net income-$1.3M+88.3%
EPS (diluted)-$0.01+92.9%

Balance sheet

See full
Cash & equivalents$88.3M-12.9%
Total debt$34.1M+3.1%
Total equity$348.5M-7.2%
Total assets$1.2B-0.7%

Cash flow

See full
Operating cash flow$12.7M-70.7%
CapEx$7.5M+1.4%
Free cash flow$5.2M-85.6%

Valuation

See full
Market cap$1.13B+80.1%
P/S+0.3×

Profitability

See full
Gross margin38.6%+1.6pp
Operating margin-3.6%-1.7pp
Net margin-3.2%-1.4pp
FCF margin6%-2.6pp

Returns & leverage

See full
Return on equity-3.8%-8.5pp
Debt / equity
Current ratio1.8×-0.3×

Where this comes from

Reported directly by ADTRAN Holdings, Inc. in its filing.

Tagged under the XBRL concept adtn:ReductionOfResearchAndDevelopmentExpenseRecognized.

The official record: ADTRAN Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADTRAN Holdings, Inc.'s reduction of research and development expense recognized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADTRAN Holdings, Inc.'s reduction of research and development expense recognized?
ADTRAN Holdings, Inc. (ADTN) reported reduction of research and development expense recognized of $2.95M in Q4 2025.
How has ADTRAN Holdings, Inc.'s reduction of research and development expense recognized changed year-over-year?
ADTRAN Holdings, Inc.'s reduction of research and development expense recognized increased by 28.3% year-over-year, from $2.3M to $2.95M.
What is the long-term trend for ADTRAN Holdings, Inc.'s reduction of research and development expense recognized?
Over 3 years (2022 to 2025), ADTRAN Holdings, Inc.'s reduction of research and development expense recognized has grown at a 120.5% compound annual growth rate (CAGR), from $1.1M to $11.8M.
What does reduction of research and development expense recognized mean?
Represents the portion of research and development costs that have been capitalized or offset by government grants, tax credits, or other cost-recovery mechanisms. This metric helps investors understand the net investment in innovation after accounting for external funding or capitalization policies.